Cambridge Medixine Join the Lab Hotel

Welcome Cambridge Medixine, the latest start-up to join the Stevenage Bioscience Catalyst campus community!

CEO and Founder Ahmet Can Berkyurek  and CSO Andreas Claas checked into our Lab Hotel in October to expand their R&D on creating a new RNA technology platform for vaccines and therapeutics.

Cambridge Medixine Ltd. (CamMed)’s vision is to deliver safer, easier, and faster medicines and therapies to the clinic, ultimately reducing the side effects experienced by patients through novel technologies inspired by natural biological phenomena, engineered and produced within the company.

Their next-generation mRNA technology is aimed at creating more efficient treatments for patients, to bring safer treatments faster to those in need.

We’re looking forward to seeing the duo grow, scale and develop their health innovation at SBC!